News
-
CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health…
-
Guest blog: Dr. Stéphane Isnard
Meet Dr. Stéphane Isnard, a CTN postdoctoral fellow who is investigating the role gut mucosa and gut microbiota…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
-
Resource CategoriesTypes
Treatment Access Group (TAG)
Welcome to the 2025 Pipeline Report. TAG’s annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
-
Resource Categories
HIV Prevention Trials Network
Gail B. Broder, Associate Director, HVTN Social and Behavioral Science & Community Engagement Unit
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTN 247: Canadian cohort of HIV+ slow progressors
A study of host and viral factors associated with disease progression in long term HIV infected subjects
-
CTN 281: EPIC 4 Study
Effectiveness of early treatment with anti-retroviral therapy in children with HIV
-
CTN 239: Phase II study of AGS-004 an immunotherapeutic agent in combination with ART followed by ART interruption
A phase II study testing the activity and safety of AGS-004 as an immunotherapeutic in successfully ART-treated subjects infected with HIV-1 in combination with ART followed by ART interruption: Trial results
-
CTN 229: Effect of AGS-004 immunotherapeutic agent in HIV-positive people on HAART
A pilot study (Phase I/II) testing the immunologic activity and safety of AGS-004, an autologous HIV immunotherapeutic, in HIV-infected adults on HAART: Trial results
-
CTN 256: Phase IIB study of efficacy and safety of AGS-004
A randomized, double blind, phase IIB study testing the efficacy and safety of AGS-004 on host control of HIV replication during analytical treatment interruption: Trial results
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.